ID: ALA558252

Max Phase: Preclinical

Molecular Formula: C14H10F2O

Molecular Weight: 232.23

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Oc1ccc(/C=C/c2cc(F)cc(F)c2)cc1

Standard InChI:  InChI=1S/C14H10F2O/c15-12-7-11(8-13(16)9-12)2-1-10-3-5-14(17)6-4-10/h1-9,17H/b2-1+

Standard InChI Key:  WPKUVKLNUGQNFZ-OWOJBTEDSA-N

Associated Targets(Human)

HT-144 176 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

SH-SY5Y 11521 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 232.23Molecular Weight (Monoisotopic): 232.0700AlogP: 3.84#Rotatable Bonds: 2
Polar Surface Area: 20.23Molecular Species: NEUTRALHBA: 1HBD: 1
#RO5 Violations: 0HBA (Lipinski): 1HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 9.00CX Basic pKa: CX LogP: 4.29CX LogD: 4.28
Aromatic Rings: 2Heavy Atoms: 17QED Weighted: 0.78Np Likeness Score: -0.13

References

1. Moran BW, Anderson FP, Devery A, Cloonan S, Butler WE, Varughese S, Draper SM, Kenny PT..  (2009)  Synthesis, structural characterisation and biological evaluation of fluorinated analogues of resveratrol.,  17  (13): [PMID:19481462] [10.1016/j.bmc.2009.05.007]
2. Liang JH, Yang L, Wu S, Liu SS, Cushman M, Tian J, Li NM, Yang QH, Zhang HA, Qiu YJ, Xiang L, Ma CX, Li XM, Qing H..  (2017)  Discovery of efficient stimulators for adult hippocampal neurogenesis based on scaffolds in dragon's blood.,  136  [PMID:28525839] [10.1016/j.ejmech.2017.05.025]

Source